Investment company raises funds for life sciences
CHESTER-based investment manager Deepbridge Capital has announced the funding of four seed stage life sciences companies based in the North West.
A total of £575,000 will be invested across Widnes-based Aurio, Manchester-based eLucid mHealth and Renephra as well as Alderley Edge-based PeptiGelDesign.
Deepbridge raised £2m via the Deepbridge Life Sciences SEIS proposition, with an initial twelve companies now funded across the UK.
The Deepbridge Life Sciences SEIS provides financial advisers and private investors the opportunity to invest in a portfolio of early stage life sciences investments, whilst benefitting from the significant potential tax reliefs available via the Government’s Seed Enterprise Investment Scheme
Dr Savvas Neophytou, partner and head of life sciences, said: “We are delighted to have completed investment in 12 new life sciences companies and are particularly excited to be working with four exciting innovations in our local region.
“The North West is a hotbed for invention. These four North West organisations epitomize this creativity and will help us grow our ambitions in the life sciences sector.
“Having searched widely for investment opportunities we are confident that our selections will maximise returns for our investors whilst funding some truly unique innovations.”
